Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

BM-PHA is as effective and safe as Restylane Perlane for improving nasolabial folds with minor side effects.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

A comprehensive scoring system for alopecia areata severity is needed.

Hair loss causes social and psychological stress, leading people to spend more on treatment, regardless of how severe the hair loss is.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Guidelines help design better trials to compare alopecia areata treatments.

Standardized photography protocols help clinicians assess and monitor hair loss effectively.

Chronic scarring alopecia is common in SLE patients and needs early detection and management.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

Alopecia areata severity in children is linked to atopy history, disease duration, and nail involvement, but not anemia.

The supplement aims to improve care for children with alopecia areata.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Gender affects the symptoms and severity of systemic lupus erythematosus.

Family history affects onset and severity of androgenic alopecia, but treatment success depends more on therapy duration.

Certain skin and family history markers predict vitiligo severity and treatment needs.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Alopecia areata affects life quality differently based on its severity.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Vaccination reduces COVID-19 severity, and some symptoms like hair loss can persist for a year.

Nail changes in alopecia areata are common and may indicate severity and genetic risk.